Riken Vitamin Co., Ltd. (TYO:4526)

Riken Vitamin Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	18,835	23,384	19,155	17,302	19,230
Short-Term Investments	3,463	-	-	-	-
Cash & Short-Term Investments	22,298	23,384	19,155	17,302	19,230
Cash Growth	-4.64%	22.08%	10.71%	-10.03%	32.27%
Accounts Receivable	20,732	23,114	20,116	18,715	18,311
Other Receivables	1,076	-	-	-	-
Receivables	21,808	23,114	20,116	18,715	18,311
Inventory	19,610	18,581	17,735	15,076	14,287
Other Current Assets	1,983	1,442	1,120	1,697	1,498
Total Current Assets	65,699	66,521	58,126	52,790	53,326
Property, Plant & Equipment	25,525	23,382	23,637	25,428	27,861
Long-Term Investments	15,078	27,355	22,338	23,267	24,294
Other Intangible Assets	980	976	645	698	681
Long-Term Deferred Tax Assets	619	540	475	474	371
Other Long-Term Assets	5,098	2	2	2	-
Total Assets	112,999	118,776	105,223	102,660	106,535
Accounts Payable	7,418	9,900	8,257	7,696	6,577
Accrued Expenses	5,683	5,618	4,808	4,656	4,841
Short-Term Debt	3,373	11,938	3,306	3,674	23,920
Current Income Taxes Payable	1,656	1,352	1,163	226	1,307
Other Current Liabilities	2,999	2,309	1,390	1,969	16,167
Total Current Liabilities	21,129	31,117	18,924	18,221	52,812
Long-Term Debt	6,541	4,115	11,254	13,860	451
Long-Term Deferred Tax Liabilities	3,808	4,626	1,579	2,038	4,285
Other Long-Term Liabilities	2,032	1,979	1,866	1,794	2,095
Total Liabilities	33,802	42,134	33,853	36,122	59,862
Common Stock	2,537	2,537	2,537	2,537	2,537
Additional Paid-In Capital	2,466	2,466	2,466	3,072	3,079
Retained Earnings	64,774	65,290	58,729	65,426	45,230
Treasury Stock	-1,952	-7,954	-1,633	-13,785	-13,804
Comprehensive Income & Other	11,335	14,273	9,245	9,269	9,114
Total Common Equity	79,160	76,612	71,344	66,519	46,156
Minority Interest	37	30	26	19	517
Shareholders' Equity	79,197	76,642	71,370	66,538	46,673
Total Liabilities & Equity	112,999	118,776	105,223	102,660	106,535
Total Debt	9,914	16,053	14,560	17,534	24,371
Net Cash (Debt)	12,384	7,331	4,595	-232	-5,141
Net Cash Growth	68.93%	59.54%	-	-	-
Net Cash Per Share	409.01	224.76	140.07	-7.07	-156.77
Filing Date Shares Outstanding	29.87	30.36	32.81	32.8	32.79
Total Common Shares Outstanding	29.87	30.36	32.81	32.8	32.79
Working Capital	44,570	35,404	39,202	34,569	514
Book Value Per Share	2649.84	2523.80	2174.34	2027.81	1407.42
Tangible Book Value	78,180	75,636	70,699	65,821	45,475
Tangible Book Value Per Share	2617.04	2491.65	2154.68	2006.53	1386.66

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.